East Asia startup investors

100&100 Ventures Corp is a venture capital and an incubation firm specializing in primary market, seed startups and early-stage investments. The firm seeks to invest through growth capital. The firm prefers to invest in innovation, digital life, blockchain ecosystem, blockchain technology, cryptocurrencies and digital asset industry. The firm prefers to invest in South Korea primarily focusing in Seoul region. 100&100 Ventures Corp was founded in 2018 and is headquartered in Seoul, South Korea.

31VENTURES is the corporate venture capital arm of Mitsui Fudosan Group, focused on co-creating new businesses and solutions by combining startup innovation with Mitsui Fudosan's extensive resources.

33N Ventures is a venture capital firm specializing in seed/startups, series A, series B and early growth ventures. It prefers to invest in Cybersecurity, Cloud Infrastructure, Data Infrastructure, AI/ML and Infrastructure Software sectors. The firm prefers to invest in companies based in Europe, Israel and North America. The firm makes equity investments from EUR 4 million ($4.64 million) to EUR 12 million ($13.92 million). 33N Ventures was founded in 2022 and is based in Porto, Portugal with additional offices in Tel Aviv, Israel,Luxembourg, and San Francisco,USA

3H Health Investment Management is a private equity and venture capital firm that prefers to invest in early, middle and later stage. It primarily invests in the healthcare industry in China. The firm prefers to invest in medicine, and in innovative medical and health technologies. 3H Health Investment Management is based in Hong Kong with an additional office in Shanghai, China.

500 Global is a venture capital firm with $2.3 billion in assets under management, investing in globally ambitious founders building fast-growing technology companies. The firm focuses on U.S. and global markets where innovation, capital, and ecosystems can propel startups and unlock long-term value. 500 Global has backed over 35 companies valued at $1 billion or more and more than 160 companies valued at over $100 million. The firm invests across sectors, geographies, and markets, leveraging its unique global networks and resources to unlock the potential of entrepreneurs and drive uncommon outcomes.

5Y Capital (formerly known as Morningside Venture Capital) is one of the first investment institutions in China engaged in early-stage venture investments. It currently manages approximately USD 5bn in dual-currency funds in USD and RMB, backed by world-renowned sovereign wealth funds, family offices, fund of funds, university endowments, pensions and foundations. Where others see crazy idealists, we see visionaries. This is how we make the world a better place.

6 Dimensions Capital was established in 2017 by a team of prominent and experienced professionals to create a leading global investment firm with a focus on innovative life science companies in China and the United States. 6 Dimensions Capital is a leading global healthcare investment firm with offices in Boston, San Francisco, Hong Kong and Shanghai. The firm focuses on the investments of healthcare startups or growth stage companies with operations in the U.S., Europe, China, Israel and other countries. We help and enable entrepreneurs to create and grow innovative healthcare businesses for the benefits of patients worldwide. INVESTMENT OPPORTUNITIES SUBMISSION We’re actively seeking opportunities to partner with committed and visionary entrepreneurs to fuel innovative businesses in both China and the United States’ life sciences sectors. We welcome you to submit non-confidential investment materials via the e-mail address below, and we will follow up with you soon if we believe there is an opportunity to further explore your submittal in detail. Disciplined Approach, Proactive Partnering 6 Dimensions Capital takes a disciplined approach in investment selection and execution. We only invest in sectors for which we have deep understanding and the ability to leverage significant support for our portfolio investments. Our investment team focuses on businesses with high growth potentials, sustainable business models and strong entrepreneurial management teams. We prefer to invest in early- and growth-stage companies specializing in biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. We actively seek collaborative partners who will work closely with our portfolio companies to develop and achieve strategic and financial outcomes, attract talent, improve financial and operating performance, and establish responsible corporate governance. Proprietary Deal Flow 6 Dimensions Capital has robust channels to access proprietary and unique deal flows and is capable of identifying some of the most desirable investment opportunities. We make it possible through extensive relationship networks, both domestically and overseas built by our investment professionals over the past decade, and our advisors add another dimension to this capability. Through our investment team’s extensive private equity experience in China, the U.S. and globally, we have accumulated deep knowledge and expertise in screening, identifying and structuring the right investment opportunities in a timely and efficient manner.

6th Man Ventures (6MV) is a Web3-native collective of investors, founders, and builders dedicated to creating a user-owned internet. Founded by a group passionate about Web3, 6MV partners with innovators to build the decentralized web. Their approach emphasizes supporting builders with capital, practical assistance, research, insights, and connections, ensuring the needs of creators are prioritized. Recognizing the importance of community in the user-owned web, 6MV leverages its experience in building communities from the ground up to assist others in doing the same. As Web3 natives, they embrace the potential of a user-owned internet, taking risks on opportunities and individuals that others might overlook. Their portfolio spans various sectors, including AI, consumer applications, decentralized physical infrastructure networks (DePIN), developer tools, gaming, and financial services, reflecting their commitment to shaping the future of the internet.

8VC is a technology and life sciences venture capital firm that builds and invests in transformative companies across various sectors, including life sciences, healthcare, manufacturing, enterprise, logistics, and defense. Founded in 2015 by Joe Lonsdale, a co-founder of Palantir Technologies, the firm is headquartered in Austin, Texas, and manages over $6 billion in committed capital. 8VC's mission is to "fix a broken world" by partnering with entrepreneurs to develop innovative solutions to complex global challenges. The firm invests at all stages of a company's lifecycle, from seed to growth, and also builds companies through its 8VC Build program. Notable portfolio companies include Palantir Technologies, Anduril Industries, and Guardant Health. 8VC's investment philosophy emphasizes long-term value creation and societal impact, focusing on sectors that have the potential to drive significant positive change. The firm's team comprises experienced professionals with diverse backgrounds in technology, finance, and entrepreneurship, enabling them to provide comprehensive support to their portfolio companies.

a16z crypto is a venture capital fund that invests in crypto and web3 startups. We have over $7.6 billion assets under management across four funds, and have been investing in web3 – across all stages – since 2013, under the direction of founding general partner Chris Dixon, as part of Andreessen Horowitz.

A key pillar in Arab Bank’s Digital Innovation Strategy, AB Ventures was set up in 2018 as the bank’s independent Corporate Venture Capital arm. AB Ventures demonstrates the bank’s commitment towards embracing digital innovation by investing directly in the next wave of innovative financial solutions, and – integrating them where relevant – into the financial services’ value chain across multiple markets.

Accelerator Ventures is a venture capital firm focused on seed-stage investments in market-leading enterprises, often providing the first institutional check.

Access Technology Ventures is the $2.5B+ venture and growth tech investment effort of Access Industries, a global $20B+ investment platform. Our portfolio includes leading technology companies such as Alibaba, Facebook, Snapchat, Spotify, Square, Rocket Internet, Zalando, Digital Ocean, Opendoor, and Yelp. Access Industries has been making long-term direct investments globally for over 30 years, with dedicated investment efforts in real estate, natural resources and chemicals, media and telecommunications, as well as technology. Among its investments, Access Industries owns a significant stake in LyondellBasell Industries, the world’s third-largest independent chemical company, and Warner Music Group, one of the world’s leading music labels. Access Industries was founded in 1986 by Len Blavatnik, an American entrepreneur and philanthropist. The group is headquartered in New York, with offices in London and Moscow.

Acrew Capital is a thesis-oriented venture firm that plays VC as a team sport. They focus on long-term partnerships from early-stage Seed and Series A rounds to growth-stage Inflection rounds.

Addin Ventures is a cross-border seed fund focused on Taiwan and the US. The firm specializes in AI-enabled digital services, data-driven digital transformation, and vertical SaaS, helping startups leverage Asian resources to expand into the US market.

AdFirst is a holding company designed to co-invest with other VCs in early and expansion stage start-ups. Along with investments, we provide strategic marketing expertise. Our focus is participation in funding rounds with other VCs as a partner and marketing expert. Our strong side is deep understanding of promoting B2C, AdTech, E-commerce business. We have broad professional network, which allows us to work with world best marketing experts and advisors.

Adjuvant Capital is a venture capital firm that finances life science technologies addressing high-burden public health challenges, including infectious diseases, maternal and child health, and nutrition, with a focus on underserved markets and emerging economies.

Germany-based global corporate venture fund focusing on investing in affiliate publishers and fortifying the core CPA-business model through investments, education, and consultancy.

Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. As one of the largest privately-owned partnerships, our 600+ colleagues across five continents leverage the full ecosystem of Advent’s global resources to support and guide our portfolio companies as they seek to achieve their strategic goals. To learn more, visit adventinternational.com.

Aeterra Capital Partners is an independent private equity firm with over $350 million under advisement, focusing on middle-market leaders with strategic growth potential across China and Asia.

Aglaé Ventures is a global technology investment firm backed by Agache (the holding company of the Arnault family). They partner with exceptional founders to build enduring, asset-light technology companies across all stages of growth.

AIF Capital is a pan-Asian middle-market private equity firm providing growth capital and expertise to help emerging businesses become regional champions, with a strong focus on lead investments.

The AI-focused fund built for and by the industry’s best.

Aju IB Investment is a leading multi-stage venture capital and private equity firm based in Korea with a global presence in Boston and Silicon Valley.

Alchemist is a global accelerator that guides technical founders from early-stage ideas to traction, providing intensive coaching, a network of over 7,000 mentors, and access to Silicon Valley capital.